NCT06592560尚未招募不适用
Diagnostic Value of Asprosin As a Biomarker in Breast Cancer
Marina Hanna Thabet Ghobrial0 个研究点目标入组 84 人开始时间: 2024年10月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 84
- 主要终点
- Diagnostic value of Asprosin as a biomarker in breast cancer
研究概览
简要总结
To evaluate the clinical utility of Asprosin measurement in breast cancer patients in comparison with healthy controls and patients with benign breast lesions.
To compare between Asprosin and the routine markers (CEA, CA15-3) as biomarkers for breast cancer diagnosis
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 60 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Females aged (40 ± 20 years) who did not receive any chemotherapy or surgical treatment and they will be divided as follow:
- •Group 1: healthy controls from healthy volunteers. Group 2: patients with benign breast lesions. Group 3: breast cancer patients.
排除标准
- •1- Female patients with any other type of malignant or benign tumors. 2- Past history of chemotherapy or surgical treatment of cancer.
结局指标
主要结局
Diagnostic value of Asprosin as a biomarker in breast cancer
时间窗: Baseline
Evaluation of the clinical utility of measurement of asprosin as a non invasive biomarker in the diagnosis of breast cancer
次要结局
- Diagnostic value of Asprosin as a biomarker in breast cancer(Baseline)
研究者
Marina Hanna Thabet Ghobrial
Assistant Lecturer
Assiut University
相似试验
进行中（未招募）
不适用
Breast cancer biomarkers and treatment targetsMalignant neoplasm of breastBreast cancerCancerISRCTN40576403niversity Hospital Southampton (UK)500
已完成
不适用
AXINAB AXirubicin-e® IN Adjuvant Breast CancerNon - interventional study on the efficacy and tolerability of epirubicin in the treatment of breast cancerSide effects of chemotherapy with Axirubicin-e with a focus on cardiotoxicity and impaired quality of life.C50Malignant neoplasm of breastDRKS00006019AxioNovo Gmbh680
撤回
不适用
Comparison of Biomarkers Based on Fine-Needle Aspiration in Women at Increased or Normal Risk of Breast CancerBreast CancerNCT00041353Fox Chase Cancer Center
Unknown
不适用
Uncovering Potential Breast Cancer Biomarkers Amp; Possible Drug Targets Using Advanced Quantitative Mass SpectrometryBreast CancerNCT01619514National University Hospital, Singapore
终止
不适用
An Observational Study Of Indian Breast Cancer Patients Receiving Adjuvant Therapy With AromasinBreast NeoplasmsNCT00776659Pfizer39